Published in J Nephrol on April 26, 2010
Estimated radiation exposure from medical imaging in hemodialysis patients. J Am Soc Nephrol (2011) 1.54
Decrease in irisin in patients with chronic kidney disease. PLoS One (2013) 1.28
The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study. Nephrol Dial Transplant (2013) 1.12
Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer (2011) 1.01
End stage and chronic kidney disease: associations with renal cancer. Front Oncol (2012) 0.98
Incorporating temporal EHR data in predictive models for risk stratification of renal function deterioration. J Biomed Inform (2014) 0.95
Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009. Am J Kidney Dis (2015) 0.92
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. World J Urol (2014) 0.92
Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study. PLoS One (2014) 0.92
Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? Kidney Int Suppl (2011) (2011) 0.89
Oncological and renal medical importance of kidney-sparing surgery. Nat Rev Urol (2013) 0.86
Dialysis-requiring acute kidney injury increases risk of long-term malignancy: a population-based study. J Cancer Res Clin Oncol (2014) 0.79
Chronic Kidney Disease is Associated With Upper Tract Urothelial Carcinoma: A Nationwide Population-Based Cohort Study in Taiwan. Medicine (Baltimore) (2016) 0.78
Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor. Int J Mol Sci (2015) 0.77
Hepatocellular carcinoma in patients with chronic kidney disease. World J Gastroenterol (2013) 0.77
Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC). Cancer Epidemiol Biomarkers Prev (2016) 0.76
Beliefs and Attitudes to Bowel Cancer Screening in Patients with CKD: A Semistructured Interview Study. Clin J Am Soc Nephrol (2017) 0.75
Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies. Mol Clin Oncol (2016) 0.75
Using the cytokinesis-block micronucleus cytome assay to evaluate chromosomal DNA damage in chronic renal patients undergoing bicarbonate haemodialysis and haemodiafiltration. J Prev Med Hyg (2016) 0.75
Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge. Biomed Res Int (2014) 0.75
Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function. Int Urol Nephrol (2015) 0.75
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases. Front Med (Lausanne) (2017) 0.75
Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine? Oncotarget (2017) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc (2003) 9.96
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) N Engl J Med (2000) 8.02
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int (2007) 7.75
Skin cancers after organ transplantation. N Engl J Med (2003) 6.65
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet (1993) 6.56
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int (2000) 3.86
The epidemiology of renal cell carcinoma. J Urol (2006) 3.85
Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28
Aristolochic acid nephropathy: a worldwide problem. Kidney Int (2008) 2.73
Nephropathy caused by Chinese herbs in the UK. Lancet (1999) 2.68
Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64
Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int (2006) 2.07
Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir Scand (1965) 1.92
Malignancy after transplantation. Transplantation (2005) 1.92
Association of albuminuria and cancer incidence. J Am Soc Nephrol (2008) 1.91
Cancer risk in patients on dialysis and after renal transplantation. Lancet (2000) 1.87
Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int (1999) 1.77
Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrol Dial Transplant (2009) 1.74
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer (2007) 1.73
Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. Am J Kidney Dis (2008) 1.71
Cancer incidence among Canadian kidney transplant recipients. Am J Transplant (2007) 1.66
An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987) N Engl J Med (1991) 1.57
Association of CKD and cancer risk in older people. J Am Soc Nephrol (2009) 1.57
Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int (2006) 1.40
Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis (2007) 1.39
Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. Am J Transplant (2007) 1.37
Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia. J Am Soc Nephrol (2007) 1.35
Skin cancer in organ transplant recipients--where do we stand today? Am J Transplant (2008) 1.35
Glomerulonephritis and malignancy: a population-based analysis. Kidney Int (2003) 1.14
Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy. Mutat Res (2007) 1.12
Balkan endemic nephropathy and associated urothelial cancer. Nat Clin Pract Urol (2008) 1.06
Series: current issues in mutagenesis and carcinogenesis, No. 65. The genotoxicity and carcinogenicity of paracetamol: a regulatory (re)view. Mutat Res (1996) 1.00
Evidence for increased cancer deaths in chronic dialysis patients. Am J Kidney Dis (1993) 0.96
Are chronic dialysis patients at increased risk for cancer? J Nephrol (2008) 0.96
Managing cancer risk and decision making after kidney transplantation. Am J Transplant (2008) 0.91
Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation (2008) 0.88
[End-stage renal insufficiency associated with Chinese herbal consumption in France]. Nephrologie (1998) 0.87
Carcinoma of the urinary tract and analgesic abuse. Med J Aust (1972) 0.84
Observations on the effect of abolishing analgesic abuse and reducing smoking on cancers of the kidney and bladder in New South Wales, Australia, 1972-1995. Cancer Causes Control (1999) 0.82
Reported cancer screening practices of nephrologists: results from a national survey. Nephrol Dial Transplant (2009) 0.82
Analgesic abuse, renal parenchymal disease and carcinoma of the kidney or ureter. Aust N Z J Med (1977) 0.80
The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure. Clin Nephrol (1989) 0.80
Renal cell carcinoma, a new complication of analgesic nephropathy. Lancet (1986) 0.79
Renal disease in patients with cancer. Nat Clin Pract Nephrol (2007) 0.79
[Development of malignant uroepithelial neoplasms in the upper urinary tracts in nephropathies caused by analgesic abuse: clinical study based on 16 cases]. J Urol Nephrol (Paris) (1979) 0.76
Epidemiologic study of analgesic abuse: mortality study in 7275 working women (1968-1987). Kidney Int (1991) 0.76